Biomarker ID | 1334 |
PMID | 24518785 |
Year | 2014 |
Biomarker | miR-182 |
Biomarker Basis | Expression Based |
Biomolecule | miRNA |
Source | Tissue |
Subjects | Humans |
Regulation | Upregulated in PCa (4.7 fold) |
Odds Ratio/Hazard Ratio/Relative Risk | OR: 0.976 (95% CI: 0.857-1.112) |
Effect on Pathways | Pathways Include: synapse; presynapse; cell junction; generation of neurons; neurogenesis |
Experiment | Prostate Cancer Vs Normal Prostate |
Type of Biomarker | Diagnostic |
Cohort | Cohort of 273 paraffin embedded prostate cancer samples was used. |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | 0.717 |
Method Used | qRT-PCR |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Validated on independent patient dataset |
Technical Name | miR-182 |